Sheel Biotech logo

Sheel Biotech financials and balance sheet

NSE: SHEELCommercial Services & Supplies

Last close ₹58.95down ₹1.10 (1.83%)

Share price at the NSE close on 23 Oct 2026. Previous close ₹60.05.

52-week range of traded prices to 23 Oct 2026
₹37.80Low, 1 Apr 2026₹86.50High, 23 Oct 2025
Market cap
₹120 Cr
P/E
10.2
P/B
0.9
Dividend yield
Nonein the last 12 months
ROE
9.3%
Debt to equity
0.07
Volume, NSE
4,000100.0% delivered

1 year at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.Sheel Biotech annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue110
  2. Materials and goods−68
  3. Employee costs−15
  4. Other expenses−11
  5. Operating profit16
  6. Depreciation−1.1
  7. Other income+0.7
  8. Finance costs−1.9
  9. Profit before tax14
  10. Tax−2.3
  11. Net profit12

What the company owns

  • Receivables₹62 Cr
  • Plant, investments and other assets₹52 Cr
  • Inventory₹30 Cr
  • Cash and bank₹2 Cr

What pays for it: net worth and liabilities

  • Net worth₹127 Cr
  • Borrowings₹9 Cr
  • Other liabilities₹7 Cr
  • Owed to suppliers₹3 Cr

Profit and loss

Standalone, ₹ crore, years to March.Sheel Biotech half-yearly results

₹ croreMar 2026Filed 28 May
Revenue from operations110
94
Materials and goods bought68
Employee costs15
Other expenses11
Operating profit before depreciation16
Operating margin14.8%
Materials, % of revenue61.8%
Employee costs, % of revenue13.4%
Other expenses, % of revenue10.1%
Depreciation and amortisation1
Operating profit after depreciation15
Other income1
Finance costs2
Profit before tax14
2
Net profit12
Net margin10.7%

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2026Filed 28 May
127
Share capital20
Reserves107
9
17
2
Total assets146
18
128
Net debt7
Borrowings are counted again inside the liabilities due within a year and after a year.

Cash flow

Standalone, ₹ crore, years to March.

₹ croreMar 2026Filed 28 May
−17.6
−15.3
−32.1
Receivables−6.7
Inventories9.8
Payables−0.3
Other working capital−34.9
Tax paid−2.3
Capital spending6.7
Free cash flow−24.2
−6.6
25.9
Dividends paid0.0
Shares issued35.6
Net change in cash1.7
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2026Filed 28 May
Earnings per share₹6.69
Diluted earnings per share₹6.69
Book value per share₹62.40
Shareholder yield−43.7%
Market cap at the year end (₹ crore)81.4

Ratios

Standalone, years to March.Sheel Biotech PE ratio and valuation

RatioMar 2026Filed 28 May
Return on equity9.3%
Return on capital employed11.2%
Cash conversion−149.4%
Interest cover7.9
Debt to equity0.07
Receivable days205
Inventory days159
Payable days16
Cash conversion cycle, days347
Working capital days386
Asset turnover0.75
Assets per rupee of net worth1.15
Sales per rupee of plant11.62
Capital spending to depreciation6.25

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2026.

Return on assets, latest year
8.1%
Cash from operations against operating profit
−107.9%

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ croreLatest year
Cash from operations−17.6
Cash from investing−6.6
Cash from financing25.9
Capital spending6.7
Dividends paid0.0
Shares issued for cash35.6
Borrowings raised0.0
Borrowings repaid1.9

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2026
Effective tax ratePublished threshold 17.16 per cent16.12
Tax charged less tax paid, % of profitOur threshold 10 percentage points−0.27
A threshold marked as ours has no published figure; it is the line we read the check against.